4 hours ago • manilatimes.net
Gain Therapeutics Offered Expanded Clinical and Biomarker Results from Phase 1b GT-02287 Study and Preclinical Data on a New Chemical Series at AD/PD 2026
4 hours ago • manilatimes.net
Gain Therapeutics Offered Expanded Clinical and Biomarker Results from Phase 1b GT-02287 Study and Preclinical Data on a New Chemical Series at AD/PD 20264 hours ago • gurufocus.com
Ovid Therapeutics OVID plans to initiate Phase 1 testing of drug OV40714 hours ago • gurufocus.com
Arvinas ARVN Announces Positive Phase 1 Trial Findings for ARV-102 for Parkinson’s Disease4 hours ago • bitget.com
Arvinas Reports Encouraging Phase 1 Results with ARV-102 Demonstrating Over 50% LRRK2 Reduction in Parkinson’s Disease Patient Cerebrospinal Fluid After6 hours ago • stocktitan.net
Ovid Therapeutics Reveals OV329 Data and Broader Use, Phase 1 Approval for OV4071, and Publishes 2025 Financials2026-03-18 • manilatimes.net
Cognition Therapeutics Showed Zervimesine’s Effects on Lewy Body Dementia Symptoms at AD/PD 20262026-03-18 • stocktitan.net
Acumen Pharmaceuticals Showcased Brain Delivery™ Research, Biomarker Studies, and New Antibodies at the International Conference on Alzheimer’s and Parkinson’s Diseases 2026’s Advances in2026-03-18 • stocktitan.net
CervoMed Announces 2025 Fourth Quarter and Full Year Financials Alongside Company News2026-03-18 • neurologylive.com
Solriamfetol Shows Benefit for Wakefulness in Obstructive Sleep Apnea Phase 3 Study2026-03-18 • anavex.com
Anavex Life Sciences Showed Notable Treatment Results for Blarcamesine in a Cutting-Edge Alpha-Synuclein Parkinson’s Disease Model at the AD/PD 20262026-03-16 • PR Newswire
PrimeC Shows Significant Clinical and Biological Effects in ALS Patients During the PARADIGM Phase 2b Trial, According to JAMA Neurology Results2026-03-14 • gurufocus.com
Oragenics’ ONP-002 Shows Progress in Phase IIa Australia Trial2026-03-12 • quiverquant.com
Arvinas Inc. will share Phase 1 trial results for ARV-102 in Parkinson’s Disease at the AD/PD 2026 event.2026-03-12 • bitget.com
CNS Pharmaceuticals Announces New Corporate Strategy Aimed at Developing a Robust Neurology and Oncology Pipeline2026-03-12 • parkinsonsnewstoday.com
Japan has given provisional acceptance to Amchepry cell therapy for Parkinson’s2026-03-12 • neurologylive.com
Brogidirsen Shows Safe Long-Term Results and Consistent Motor Control in DMD Patients2026-03-12 • neurologylive.com
FDA is reviewing Capricor’s Deramiocel cell therapy for DMD Cardiomyopathy2026-03-12 • parkinsonsnewstoday.com
United States and China regulators approve stem cell therapy trials for progressive multiple sclerosis.2026-03-11 • tinygems.com
CNS Pharmaceuticals Inc. announces a new strategy concentrating on neurology and oncology pipeline growth.2026-03-12 • EIN Presswire
Child Neurology Foundation Names Ambry Genetics Top Level Partner2026-03-11 • EIN Presswire
Isaac Health Introduces Virtual Lifestyle Medicine Program Focused on Neurology to Lower Dementia Risk2026-03-11 • EIN Presswire
Tampa Bay Functional Neurology Broadens Gulf Coast Availability of Concussion Recovery Services2026-03-11 • globenewswire.com
Oragenics Granted HREC Clearance to Proceed with ONP-002 Phase IIa Trial for Concussion and Mild Traumatic Brain Injury in Australia2026-03-11 • m.in.investing.com
Guggenheim increases Xenon Pharmaceuticals stock price target following trial results2026-03-11 • fiercebiotech.com
Xenon phase three epilepsy results significantly exceeded forecasts, driving a sharp increase in the company’s stock price2026-03-11 • manilatimes.net
Rapport Therapeutics Announces 2025 Fourth Quarter and Full Year Financials and Offers Business News2026-03-11 • manilatimes.net
NMD Pharma unveiled a late-breaking oral presentation at the MDA Conference showcasing key safety and effectiveness results from SYNAPSE-CMT, a Phase 2a clinical trial examining ignaseclant2026-03-11 • insights.citeline.com
Xenon’s drug seizure data strongly support clinical application2026-03-10 • statnews.com
Xenon Pharmaceuticals’ seizure medication demonstrated significant effectiveness during final trials2026-03-10 • parameter.io
XENE Stock Soars 40 Percent Following Epilepsy Drug Trial Success54 minutes ago • prnewswire.co.uk
Poultry Diagnostics Market worth $0.25 billion by 2031 | MarketsandMarkets™1 hour ago • prnewswire.co.uk
MarketsandMarkets Awarded on the Forbes America's Best Management Consulting Firms 2026 List1 hour ago • prnewswire.co.uk
Digital Asset Management Market worth $14.51 billion by 2031 | MarketsandMarkets™1 hour ago • prnewswire.co.uk
Algorand Foundation and Algorand Technologies Unify Ecosystem Operations Through Strategic Agreement2 hours ago • prnewswire.co.uk
ReOrbit and SLI sign €150m contract for small GEO satellites4 hours ago • prnewswire.co.uk
Bybit Launches Gold Product with Tokenized Gold Yield Opportunities4 hours ago • theobserver.ca
Sarnia and Aamjiwnaang water system improvements completed at lower cost4 hours ago • edmonton.taproot.news
Automated truss construction featured in initial program initiatives4 hours ago • economymiddleeast.com
Sharjah Bank announces highest ever 2025 profit with improving performance4 hours ago • mining.com
Orla obtains last approval to proceed with subterranean digging near Camino Rojo4 hours ago • scanx.trade
Avio Smart Market Stack and Kissan Agri Mall Announce MoU for Project AVIO Agritech4 hours ago • european-biotechnology.com
Biotech Alliances Across Europe9 minutes ago • EIN Presswire
Kevin Mackey and Christie Kramer-Codner of Epoch Concepts Named to 2026 Colorado Titan 10024 minutes ago • EIN Presswire
Yamamoto Announces Midwest Laundries Inc. as Primary Distributor for Greater Chicagoland and Southern Wisconsin24 minutes ago • EIN Presswire
Vibes Tribe Launches First Digital Platform Focused on Nervous System Regulation for Midlife Women2026-03-17 • apk-inform.com
The Russian ministry of agriculture increased the wheat export levy2026-03-17 • russiaspivottoasia.com
Russian agricultural export revenues to the Eurasian Economic Union are projected to increase by 23% in 2025.2 hours ago • PR Newswire
Infineon partners with Zenergize to enable India-designed power-electronics for the country's energy transition3 hours ago • PR Newswire
NIPER Raebareli partners with Roche Pharma to Strengthen Pharmaceutical Education and Research Capability Building Collaboration4 hours ago • economictimes.indiatimes.com
AM/NS will begin construction of the large Andhra facility next week2 hours ago • PR Newswire
Loyalzoo Unveils Integrated CRM and Advanced Loyalty Functionality for New MX™ POS Smart Terminals4 hours ago • intlbm.com
Cambridge IFA releases the Islamic Financial Times application3 hours ago • PR Newswire
Tetragon Financial Group Limited Provides Tax Reporting to U.S. InvestorsStay ahead with real-time headlines from top sources, categorized by sector and country.